| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $4.0M | -77.8% |
| SG&A Expense | $11.4M | +17.3% |
| Operating Income | -$16.3M | +41.1% |
| Income Tax | $0 | — |
| Net Income | -$15.7M | +42.4% |
| EPS (Basic) | -$3.42 | +43.2% |
| EPS (Diluted) | -$3.42 | +43.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.3M | +233.3% |
| Current Assets | $18.3M | -16.5% |
| Total Assets | $106.0M | +381.7% |
| Current Liabilities | $4.4M | +29.6% |
| Total Liabilities | $7.7M | +127.9% |
| Stockholders' Equity | $6.9M | -63.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.8M | +20.3% |
| Investing Cash Flow | $16.2M | -38.8% |
| Financing Cash Flow | $15.8M | — |